Enhancement of dissolution of poorly water-soluble drugs using proliposomes

American Pharmaceutical Review

Volumn 11, Issue 3, 2008, Pages

  Betageri, Guru V ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLCHOLINE; EXEMESTANE; FAMOTIDINE; FENOFIBRATE; GLIBENCLAMIDE; LACTOSE; LIPOSOME; POLYSORBATE 80; PROFENAMINE; PROGESTERONE; TESTOSTERONE;

DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; HUMAN; IN VITRO STUDY; NONHUMAN; REVIEW; TRANSMISSION ELECTRON MICROSCOPY;

EID: 55849092058     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Dapergolas G, Gregoriadis G 1976. Hypoglycaemic effect of liposome-entrapped insulinadministered intragastrically into rats. Lancet, 16: 824-827.
2. Patel H, Ryman B 1976. Oral administration of insulin by encapsulation within liposomes. FEBS Lett., 62:60-63.
3. Rogers JA, Anderson KE 1998. The potential of liposomes in oral drug delivery. Crit. Rev. Ther. Drug Car. Sys. 15: 421-480.
4. Payne NI, Browning I, Hynes CA 1986. Characterization of proliposomes. J. Pharm. Sci., 75: 330-333.
5. Katare OP, Vyas SP, Dixit VK 1991. Proliposomes of Indomethacin for oral administration. J. Microencap. 8:1-7.
6. Ahn BN, Kim SK, Shim CK 1995. Preparation and evaluation of proliposomes containing propranolol hydrochloride. J. Microencap. 12: 363-375.
7. Betageri GV 2002. Delivery of Liposomal Formulations by Oral or Transdermal Route. Progress in Drug Delivery System, XI: 77-95.
8. Prabhu S, Brocks DR, Betageri GV 2001. Enhancement of dissolution of ethopropazine using solid dispersions prepared with phospholipid and/or polyethylene glycol. Drug Dev. Ind. Pharm. 27: 413-418.
9. Potluri P, Betageri, GV 2006. Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone. Drug Del., 13: 227-232.
10. Devabhaktuni V 2007. Application of proliposomal technology to oral drug delivery of hydrophobic drugs. M.S. Thesis 32-44.
11. Danesaru R, Danesaru R 1989. Development of a new coatedbead dosage form of sodium iodide I-131. Int. J. Pharm. 49: 115-119.
12. Bhat SU, Lalla JK 1995. Look at process costing and cost-effectiveness of a pharmaceutical formulation. Indian Drugs, 32: 551-560.
13. Kumar R, Gupta RB, Betageri GV 2001. Formulation, characterization, and in vitro release of glyburide from proliposomal beads. Drug Del. 8: 25-27
14. Banker GS, Anderson NR 1991. "Tablets" in The Theory and Practice of Industrial Pharmacy, edited by Lachman, L., Lieberman, H. A. and Kanig, L. J., 4th edition, Lea & Febiger.
15. Hilgers AR, Conradi RA, Burton PS 1990. Caco-2 cell monolayers as model for drug transport across the intestinal mucosa. Pharm. Res. 7: 902-910.
16. Iwanaga K, Ono S, Narioka K, Kakemi M, Yamashita S, Nagano M, Oku N 1997. Oral Delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract. Int. J. Pharm., 157: 73-80.
17. Deshmukh DD, Ravis WR Betageri GV, 2008. Improved delivery of cromolyn from oral proliposomal beads. Int. J. Pharm.
18. Pagano RE, 1981. In "Liposomes from physical structure to therapeutic applications", Edited by Knight, C. G., Elsevier/North-Holland Biomedical Press, NY.
19. Brocks DR. Betageri GV 2002. Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation. J. Pharm. Pharmacol. 54: 1049-1053.
20. Shah NM, Parikh J, Namdeo, A 2006. Subramanian, N., and Bhowmick, S., Preparation, characterization and in vivo studies of proliposomes containing cyclosporine. A., J. Nanosci. Nanotechnol., 6: 2967-2973.
21. Song KH, Chung, SJ, and Shim, CK, 2005. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J. Control. Rel. 106: 298-308.
22. Ning MY, Guo YZ, Pan HZ, Yu HM, Gu ZW 2005. Preparation and Evaluation of proliposomes containing clotrimazole. Chem. Pharm. Bull. 53: 620-624.
23. Betageri GV 2004. Enteric-coated proliposomal formulations for poorly water soluble drugs. US Patent # 6,759,058.
24. Betageri GV 2005. Proliposomal drug delivery system. US Patent # 6,849,269.